Skip to content

A multicenter study on the correlation between cognitive dysfunction and hypoxic respiratory diseases

A multicenter study on the correlation between cognitive dysfunction and hypoxic respiratory diseases

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500113729
Enrollment
Unknown
Registered
2025-12-02
Start date
2025-07-18
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic obstructive pulmonary disease, sleep apnea

Interventions

Chronic obstructive pulmonary disease with sleep apnea group:None
Control group:None

Sponsors

Shanghai Minhang District Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: OSA patients: apnea-hypopnea index (AHI) >= 5 COPD patients: post-bronchodilator pulmonary function test showing FEV1/FVC 18 years and < 80 years, education level at least junior high school or above, able to cooperate and complete all assessments

Exclusion criteria

Exclusion criteria: 1. Patients with severe cardiovascular diseases, liver or kidney failure, recent strokes, or dementia; 2. Patients with severe infections or mental disorders; 3. Patients who are heavy drinkers or have a history of long-term alcohol consumption, or those taking sedatives or hypnotics; 4. Patients with serious conditions such as malignant tumors and undergoing relevant drug treatments; 5. Patients who have undergone any treatment (including weight loss, medication, oral appliances, continuous positive airway pressure ventilation, etc.); 6. Patients unable to cooperate with the assessment; 7. Patients with endocrine disorders such as hyperthyroidism; 8. Patients with brain injury, depression, epilepsy, etc.; 9. Patients with organic brain lesions (e.g., cerebral hemorrhage, tumor, cyst) identified by routine MRI scans; 10. Patients with contraindications to MRI scans, such as implanted metal devices or claustrophobia.

Design outcomes

Primary

MeasureTime frame
The incidence rate of cognitive impairment;Lung function;Sleep respiratory monitoring;Blood oxidative stress indicators;Brain MRI;

Countries

China

Contacts

Public ContactYu Suyun

Shanghai Minhang District Central Hospital

xiaoyuer8022@163.com+86 181 4976 9965

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026